The present invention relates to stable formulations of Neisseria meningitis r LP2086 Subfamily B Antigens in immunogenic compositions. The present invention also relates to methods of preserving the conformation of Neisseria meningitis rLP2086 Antigens and methods for determining the potency of Neisseria meningitis r LP2086 antigens.